Canopy Growth (CGC) Total Debt (2017 - 2026)
Canopy Growth (CGC) reported Total Debt of $170.2 million for Q1 2026, down 19.7% on a YoY basis from $211.9 million in Q1 2025, and up 5.47% sequentially from $161.3 million in Q4 2025.
Canopy Growth (CGC) Total Debt (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Total Debt data on file, last reported at $170.2 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 19.7% year-over-year to $170.2 million; the trailing twelve-month figure through Mar 2026 stood at $170.2 million (down 19.7% YoY), and the FY2026 full-year result was $170.2 million, down 19.7% from the prior year.
- Total Debt climbed to $170.2 million in Q1 2026, from $161.3 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $1.2 billion in Q1 2022 to a low of $161.3 million in Q4 2025.
- A 5-year average of $556.2 million and a median of $443.2 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt dropped 5.25% in 2022 and slumped 59.16% in 2025, its largest moves.
- Tracing CGC's Total Debt over 5 years: stood at $888.2 million in 2022, then tumbled by 49.38% to $449.6 million in 2023, then declined by 29.69% to $316.1 million in 2024, then plunged by 48.96% to $161.3 million in 2025, then gained by 5.47% to $170.2 million in 2026.
- Business Quant data shows CGC's Total Debt at $170.2 million in Q1 2026, $161.3 million in Q4 2025, and $165.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 170.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170.17 Mn |
| Dec 31, 2025 | 161.34 Mn |
| Sep 30, 2025 | 165.80 Mn |
| Jun 30, 2025 | 213.12 Mn |
| Mar 31, 2025 | 211.91 Mn |
| Dec 31, 2024 | 316.10 Mn |
| Sep 30, 2024 | 406.00 Mn |
| Jun 30, 2024 | 410.13 Mn |
| Mar 31, 2024 | 443.21 Mn |
| Dec 31, 2023 | 449.59 Mn |
| Sep 30, 2023 | 508.12 Mn |
| Jun 30, 2023 | 777.98 Mn |
| Mar 31, 2023 | 966.70 Mn |
| Dec 31, 2022 | 888.17 Mn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 1.18 Bn |
| Dec 31, 2021 | 1.20 Bn |
| Sep 30, 2021 | 1.21 Bn |
| Jun 30, 2021 | 1.27 Bn |